glp-1 constipation law office in west virginia The hidden risks of weight loss prescriptions glp-1 constipation law firm in

plantarum , Lb

112 DAN encompasses multiple subtypes, including cardiovascular autonomic neuropathy (CAN), gastrointestinal autonomic neuropathy, genitourinary autonomic neuropathy, sudomotor dysfunction, hypoglycemia unawareness, and pupillary dysfunction, each affecting different organ systems and presenting a spectrum of clinical manifestations

All participants were taking a weight loss medication: semaglutide (Ozempic or Wegovy), dulaglutide (Trulicity), or tirzepatide (Zepbound or Mounjaro)

This concept evolved the field beyond compositional analysis into a functional analysis of the metabolic output of the gut population [227] with alterations in microbial metabolic pathways identified in stress-related disorders [228, 229]